The Affiliated People's Hospital Of Ningbo University
Clinical trials sponsored by The Affiliated People's Hospital Of Ningbo University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New cocktail aims to stop Chemo-Induced sickness in stem cell transplants Results expected Sep 2027 (estimated)
-
Can a reduced-intensity drug combo tame high-risk myeloma in frail older patients?
Disease control Not yet recruitingThis trial tests whether a combination of isatuximab plus a reduced-intensity version of standard chemotherapy (VRDlite) can effectively treat newly diagnosed multiple myeloma in frail older adults who are not candidates for a stem cell transplant. The study focuses on patients w…
Phase 2/3 • Sponsor: The Affiliated People's Hospital of Ningbo University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New drug aims to stop deadly complication in leukemia therapy
Prevention Not yet recruitingThis study tests whether the drug Lisaftoclax can prevent differentiation syndrome (DS), a severe and sometimes life-threatening side effect, in people with acute promyelocytic leukemia (APL) who are receiving standard treatment. About 60 participants aged 16 and older will take …
Phase 2/3 • Sponsor: The Affiliated People's Hospital of Ningbo University • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC